Search

everythinglearnresearchcommunity

for

Search:↓

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

PEGylated flavonoid Aspasomes improve brain protection and memory in stress-related disorders.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Anti-aging peptides can improve skin appearance but need better delivery methods and more research.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tislelizumab can cause cutaneous lupus erythematosus.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

Calancardin B may help reduce inflammation in immune cells.

Fluorescent proteins help visualize and understand tumor blood vessel growth.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Tofacitinib significantly improved skin and hair conditions without side effects.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

A peptide from hair follicle stem cells promotes hair growth by activating specific skin cells.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

A new compound effectively inhibits human 5α-reductase 1.

The new drug carriers show promise for better targeting and treating ovarian cancer.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.